7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors. 2020

Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
Latvian Institute of Organic Synthesis, Riga, Latvia.

A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging to the homosulfocoumarin chemotype, were assayed as inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). Four pharmacologically relevant human (h) isoforms were investigated, the cytosolic hCA I and II and the transmembrane, tumour-associated hCA IX and XII. No relevant inhibition of hCA I and II was observed, whereas some of the new derivatives were effective, low nanomolar hCA IX/XII inhibitors, making them of interest for investigations in situations in which the activity of these isoforms is overexpressed, such as hypoxic tumours, arthritis or cerebral ischaemia.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D002256 Carbonic Anhydrases A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1. Carbonate Dehydratase,Carbonic Anhydrase,Anhydrases, Carbonic,Dehydratase, Carbonate
D002257 Carbonic Anhydrase Inhibitors A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. Carbonate Dehydratase Inhibitor,Carbonate Dehydratase Inhibitors,Carbonic Anhydrase Inhibitor,Carboxyanhydrase Inhibitor,Carboxyanhydrase Inhibitors,Anhydrase Inhibitor, Carbonic,Dehydratase Inhibitor, Carbonate,Inhibitor, Carbonate Dehydratase,Inhibitor, Carbonic Anhydrase,Inhibitor, Carboxyanhydrase,Inhibitors, Carbonate Dehydratase,Inhibitors, Carbonic Anhydrase,Inhibitors, Carboxyanhydrase
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071231 Carbonic Anhydrase IX A carbonic anhydrase and transmembrane protein that consists of an N-terminal PROTEOGLYCAN-like domain, a catalytic region, a single-pass transmembrane domain, and a short intracellular tail. It functions as a dimer and is expressed primarily by cells of the GASTROINTESTINAL TRACT; BILE DUCT EPITHELIUM; and GALL BLADDER. It is expressed at high levels in many solid tumors, especially CLEAR CELL RENAL CARCINOMA, in response to CELL HYPOXIA. CAIX Protein,Carbonic Anhydrase 9
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013846 Thiepins
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
January 2015, Organic & biomolecular chemistry,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
January 2020, Bioorganic chemistry,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
November 2023, Molecules (Basel, Switzerland),
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
March 2022, ChemMedChem,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
December 2020, Journal of enzyme inhibition and medicinal chemistry,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
January 2013, Journal of medicinal chemistry,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
July 2016, Bioorganic & medicinal chemistry,
Aleksandrs Pustenko, and Alessio Nocentini, and Anastasija Balašova, and Mikhail Krasavin, and Raivis Žalubovskis, and Claudiu T Supuran
September 2022, Pharmaceuticals (Basel, Switzerland),
Copied contents to your clipboard!